Clinical trials
Phase 4 Skin Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clinigen, Inc. | 2 |
| Baylor Research Institute | 1 |
| Dana-Farber Cancer Institute | 1 |
| Goldman, Butterwick, Fitzpatrick and Groff | 1 |
| University Hospitals Cleveland Medical Center | 1 |
| University of Minnesota | 1 |
| University of Oklahoma | 1 |
| VA Office of Research and Development | 1 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 10 |
| Melanoma | 2 |
| Postoperative Pain | 2 |
| Acute Pain | 1 |
| Basal Cell Carcinoma | 1 |
| Carcinoma | 1 |
| Carcinoma, Squamous Cell | 1 |
| Cicatrix | 1 |
| Cutaneous Squamous Cell Carcinoma | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.